The outlook revision reflects Moody’s Investors Service’s expectation that Kennedy will continue to generate favorable operating performance while maintaining solid balance sheet metrics.
Moody’s also affirmed Kennedy’s “A3” rating on $63.6 million of outstanding bonds. The affirmation is based on Kennedy’s strong operating performance and favorable volume growth.
More articles on healthcare finance:
Massachusetts hospitals to lose $84M due to Partners’ math errors
4 questions with Sparrow’s new VP of revenue cycle
Will billing requirements change for Washington healthcare companies?
